Advertisement

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo

Published:October 24, 2005DOI:https://doi.org/10.1016/j.jaci.2005.08.044

      Background

      Intranasal corticosteroids used with antibiotics are known to improve rhinosinusitis symptoms compared with antibiotic therapy alone. However, the efficacy of intranasal corticosteroid monotherapy for acute, uncomplicated rhinosinusitis is not established.

      Objectives

      To evaluate efficacy and safety of mometasone furoate nasal spray (MFNS) versus amoxicillin and placebo in patients with acute, uncomplicated rhinosinusitis.

      Methods

      In this double-blind, double-dummy trial, subjects (≥12 years; N = 981) were randomized to MFNS 200 μg once daily or twice daily for 15 days, amoxicillin 500 mg 3 times daily for 10 days, or respective placebo. Follow-up was 14 days. The primary efficacy endpoint was mean am/pm major symptom score over the treatment phase. Secondary efficacy endpoints included total symptom score. Safety assessments included disease recurrence during follow-up and adverse event monitoring.

      Results

      Mometasone furoate nasal spray 200 μg twice daily was significantly superior to placebo (P < .001) and amoxicillin (P = .002) at improving major symptom score. Starting on day 2, MFNS 200 μg twice daily improved total symptom score throughout treatment versus amoxicillin (P = .012) and placebo (P < .001). Global response to treatment was significantly greater with MFNS 200 μg twice daily versus amoxicillin (P = .013) and placebo (P = .001). Although significantly superior to placebo, MFNS 200 μg once daily was not superior to amoxicillin for the primary or secondary efficacy endpoints. All treatments were well tolerated with a similar incidence of adverse events.

      Conclusion

      In patients with acute, uncomplicated rhinosinusitis, MFNS 200 μg twice daily produced significant symptom improvements versus amoxicillin and placebo, without predisposing the patient to disease recurrence or bacterial infection.

      Key words

      Abbreviations used:

      MFNS (Mometasone furoate nasal spray), MSS (Major symptom score), TSS (Total symptom score)
      To read this article in full you will need to make a payment

      References

        • Bachert C.
        • Hormann K.
        • Mosges R.
        • Rasp G.
        • Riechelmann H.
        • Muller R.
        • et al.
        An update on the diagnosis and treatment of sinusitis and nasal polyposis.
        Allergy. 2003; 58: 176-191
        • Spector S.L.
        • Bernstein I.L.
        • Li J.T.
        • Berger W.E.
        • Kaliner M.A.
        • Schuller D.E.
        • et al.
        Parameters for the diagnosis and management of sinusitis.
        J Allergy Clin Immunol. 1998; 102: S107-S144
        • Anon J.B.
        • Jacobs M.R.
        • Poole M.D.
        • Ambrose P.G.
        • Benninger M.S.
        • Hadley J.A.
        • et al.
        Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.
        Otolaryngol Head Neck Surg. 2004; 130: 1-45
        • de Ferranti S.D.
        • Ioannidis J.P.
        • Lau J.
        • Anninger W.V.
        • Barza M.
        Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? a meta-analysis.
        BMJ. 1998; 317: 632-637
        • Stalman W.
        • van Essen G.A.
        • van der Graaf Y.
        • de Melker R.A.
        The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? a placebo-controlled double-blind randomized doxycycline trial.
        Br J Gen Pract. 1997; 47: 794-799
        • van Buchem F.L.
        • Knottnerus J.A.
        • Schrijnemaekers V.J.
        • Peeters M.F.
        Primary-care-based randomised placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis.
        Lancet. 1997; 349: 683-687
        • Williams Jr., J.W.
        • Aguilar C.
        • Cornell J.
        • Chiquette E.
        • Makela M.
        • Holleman D.R.
        • et al.
        Antibiotics for acute maxillary sinusitis.
        Cochrane Database Syst Rev. 2003; (CD000243)
        • Felmingham D.
        • Reinert R.R.
        • Hirakata Y.
        • Rodloff A.
        Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin.
        J Antimicrob Chemother. 2002; 50: 25-37
        • Hickner J.M.
        • Bartlett J.G.
        • Besser R.E.
        • Gonzales R.
        • Hoffman J.R.
        • Sande M.A.
        Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background.
        Ann Intern Med. 2001; 134: 498-505
        • Meltzer E.O.
        • Orgel H.A.
        • Backhaus J.W.
        • Busse W.W.
        • Druce H.M.
        • Metzger W.J.
        • et al.
        Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis.
        J Allergy Clin Immunol. 1993; 92: 812-823
        • Barlan I.B.
        • Erkan E.
        • Bakir M.
        • Berrak S.
        • Basaran M.M.
        Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children.
        Ann Allergy Asthma Immunol. 1997; 78: 598-601
        • Dolor R.J.
        • Witsell D.L.
        • Hellkamp A.S.
        • Williams Jr., J.W.
        • Califf R.M.
        • Simel D.L.
        Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
        JAMA. 2001; 286: 3097-3105
        • Meltzer E.O.
        • Charous B.L.
        • Busse W.W.
        • Zinreich S.J.
        • Lorber R.R.
        • Danzig M.R.
        Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group.
        J Allergy Clin Immunol. 2000; 106: 630-637
        • Nayak A.S.
        • Settipane G.A.
        • Pedinoff A.
        • Charous B.L.
        • Meltzer E.O.
        • Busse W.W.
        • et al.
        Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis.
        Ann Allergy Asthma Immunol. 2002; 89: 271-278
        • Berkowitz R.B.
        • Roberson S.
        • Zora J.
        • Capano D.
        • Chen R.
        • Lutz C.
        • et al.
        Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting.
        Allergy Asthma Proc. 1999; 20: 167-172
        • Bronsky E.A.
        • Aaronson D.W.
        • Berkowitz R.B.
        • Chervinsky P.
        • Graft D.
        • Kaiser H.B.
        • et al.
        Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis.
        Ann Allergy Asthma Immunol. 1997; 79: 51-56
        • Davies R.J.
        • Nelson H.S.
        Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis.
        Clin Ther. 1997; 19: 27-38
        • Graft D.
        • Aaronson D.
        • Chervinsky P.
        • Kaiser H.
        • Melamed J.
        • Pedinoff A.
        • et al.
        A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray.
        J Allergy Clin Immunol. 1996; 98: 724-731
        • Schenkel E.
        Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis.
        Exp Opin Pharmacother. 2003; 4: 1579-1591
        • Scheid D.C.
        • Hamm R.M.
        Acute bacterial rhinosinusitis in adults, part II: treatment.
        Am Fam Physician. 2004; 70: 1697-1704
        • Osguthorpe J.
        Adult rhinosinusitis: diagnosis and management.
        Am Fam Physician. 2001; 63: 69-76
        • Casale T.B.
        • Andrade C.
        • Qu R.
        Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
        Allergy Asthma Proc. 1999; 20: 193-198
        • Bucher H.C.
        • Tschudi P.
        • Young J.
        • Periat P.
        • Welge-Luussen A.
        • Zust H.
        • et al.
        Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
        Arch Intern Med. 2003; 163: 1793-1798
      1. Roper Public Affairs Group of NOP World. Impact of nasal congestion among allergic rhinitis sufferers. An internet survey of 2002 adult rhinitis sufferers with nasal congestion or parents of a child with allergic rhinitis with nasal congestion. May-June 2004.

        • Corey J.P.
        • Houser S.M.
        • Ng B.A.
        Nasal congestion: a review of its etiology, evaluation, and treatment.
        Ear Nose Throat J. 2000; 79: 690-693